Scientific Journals

	Original Artikel	Datum	Titel	Autoren Alle Autoren
1	[GO]	2025―Mrz―27	Production of recombinant nucleocapsid protein SARSN1 and its use to assess the immune response after vaccination of mice with a live probiotic vaccine containing the nucleocapsid protein of coronavirus	T. V. Gupalova, E. A. Bormotova, G. F. Leontieva, T. A. Kramskaya, Yu. A. Desheva, A. N. Suvorov
2	[GO]	2025―Feb―19	Immunogenicity of DNA vaccines against COVID-19, which encodes B and T cell immunogens with co-injection	M. B. Borgoyakova, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, E. V. Tigeeva, V. A. Yakovlev, et al. (+4) D. N. Kisakov, L. A. Kisakova, L. I. Karpenko, A. A. Ilyichev
3	[GO]	2025―Jan―27	Differentiation of the cytokine profile modified by SARS-CoV-2 and Influenzavirus in an in vitro experiment	N. V. Zaitseva, K. G. Starkova, O. V. Dolgikh, V. B. Alekseev
4	[GO]	2024―Dez―27	Analysis of increased false-positive ELISA results for HIV in blood of donors infected with SARS-CoV-2	H. Lin, Z. Wang, Q. Ren, Z. Cai, F. Ge, W. Yuan, et al. (+5) T. Liao, Y. Wu, R. Peng, Y. Gu, Y. Kuang
5	[GO]	2024―Sep―28	Relationship between HLA-II Gene Polymorphisms and Immune Response in COVID-19 Survivors and Volunteers Vaccinated against This Infection	V. I. Dubrovina, D. D. Bryukhova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov
6	[GO]	2024―Aug―02	Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2	E. A. Volosnikova, N. V. Volkova, V. V. Ermolaev, M. B. Borgoyakova, V. S. Nesmeyanova, A. V. Zaykovskaya, et al. (+5) O. V. Pyankov, B. N. Zaitsev, S. V. Belenkaya, A. A. Isaeva, D. N. Shcherbakov
7	[GO]	2024―Jun―19	Correction to: Ratios between the Levels of IL-18, Free IL-18, and IL-18-Binding Protein Depending on the Severity and Outcome of COVID-19	A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev
8	[GO]	2024―Jun―19	Factors of Interleukin-6 Signaling in COVID-19 Patients with Lung Damage of Varying Degrees: A Pilot Study	A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, D. T. Kuchiev, N. V. Gomyranova, F. N. Paleev
9	[GO]	2024―Jun―19	Endothelin Level in Menopausal Women with Comorbidity of the Acute Phase Middle Severity COVID-19 with Arterial Hypertension and Type 2 Diabetes Mellitus	N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, O. A. Nikitina, L. V. Rychkova, M. A. Darenskaya, et al. (+2) A. G. Petrova, L. I. Kolesnikova
10	[GO]	2024―Jun―19	Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac	V. O. Omelchenko, Yu. D. Kurochkina, A. V. Fedorova, V. S. Ovchinnikov, V. V. Koval, I. V. Bratko, et al. (+2) E. A. Letyagina, M. A. Korolev
11	[GO]	2024―Jun―19	Delivery of Experimental mRNA Vaccine Encoding the RBD of SARS-CoV-2 by Jet Injection	D. N. Kisakov, L. A. Kisakova, S. V. Sharabrin, V. A. Yakovlev, E. V. Tigeeva, M. B. Borgoyakova, et al. (+6) E. V. Starostina, A. V. Zaikovskaya, A. P. Rudometov, N. B. Rudometova, L. I. Karpenko, A. A. Ilyichev
12	[GO]	2024―Mai―22	Relationship between HLA-II gene polymorphisms and immune response in COVID-19 survivors and volunteers vaccinated against this infection	V. I. Dubrovina, D. D. Bryukhova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov
13	[GO]	2024―Mrz―15	Ratios between the Levels of IL-18, Free IL-18, and IL-1β-Binding Protein Depending on the Severity and Outcome of COVID-19	A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev
14	[GO]	2024―Mrz―15	Safety Assessment: a Comparative Analysis of Quantitative Content of Bacterial Endotoxins and Evaluation of Pyrogenicity of the Kazakhstan Vaccine QazCovid-in® against COVID-19	K. K. Jekebekov, A. S. Nurpeisova, Zh.S. Abay, K. A. Shorayeva, Zh.S. Absatova, R. T. Abitayev, et al. (+10) E. Zh. Kalimolda, S. U. Moldagulova, N. N. Assanzhanova, A. D. Omurtay, Ye.A. Shayakhmetov, S. O. Sadikaliyeva, K. B. Barakbayev, M. M. Kassenov, K. D. Zakarya, Ye.O. Abduraimov
15	[GO]	2024―Feb―29	Use of adjuvant compositions based on squalene ensures the induction of neutralizing antibodies against SARS-CoV-2	E. A. Volosnikova, N. V. Volkova, V. V. Ermolaev, M. B. Borgoyakova, V. S. Nesmeyanova, A. V. Zaykovskaya, et al. (+5) O. V. Pyankov, B. N. Zaitsev, S. V. Belenkaya, A. A. Isaeva, D. N. Shcherbakov
16	[GO]	2024―Feb―12	Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen)	K. G. Starkova, O. V. Dolgikh, I. N. Alikina, O. A. Kazakova, N. A. Nikonoshina, V. B. Alekseev
17	[GO]	2024―Jan―09	Analysis of the Morphology of Monocytes and Lymphocytes from COVID-19 Patients Using Low-Voltage Scanning Electronic Microscopy	A. A. Velmiskina, Yu. V. Nikitin, V. Yu. Mikhailovskii, S. V. Mosenko, A. Yu. Anisenkova, S. V. Apalko, et al. (+6) N. N. Sushentseva, S. G. Scherbak, A. M. Ivanov, N. K. Galaktionov, O. V. Shneider, K. A. Kondratov
18	[GO]	2024―Jan―08	Features of Distribution of the Allelic Variant of the OAS1 Gene Associated with Severe Form of the Coronavirus Infection in the Russian and Global Populations	M. V. Olkova, S. M. Koshel, V. S. Petrushenko, A. A. Alimov
19	[GO]	2023―Dez―29	Factors of interleukin 6 signalling in COVID-19 patients with varied degree of lung injury: a pilot study	А. А. Korotaeva, E. V. Samoilova, N. V. Pogosova, D. T. Kuchiev, N. V. Gomyranova, F. N. Paleev
20	[GO]	2023―Dez―29	Endothelin level in climacteric women with comorbidity of the acute phase middle severity COVID-19 with arterial hypertension and type 2 diabetes mellitus	N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, O. A. Nikitina, L. V. Rychkova, M. A. Darenskaya, et al. (+2) A. G. Petrova, L. I. Kolesnikova
21	[GO]	2023―Dez―29	Analysis of T-cell and humoral immune response to SARS-CoV-2 antigens in vaccinized combined vector vaccine "Gam-COVID-Vac" in rheumatoid arthritis patients taking rituximab	V. O. Omelchenko, Yu. D. Kurochkina, A. V. Fedorova, V. S. Ovchinnikov, V. V. Koval, I. V. Bratko, et al. (+2) E. A. Letyagina, M. A. Korolev
22	[GO]	2023―Dez―29	Delivery of experimental mRNA vaccine, encoding the RBD of SARS-CoV-2 using jet injection	D. N. Kisakov, L. A. Kisakova, S. V. Sharabrin, V. A. Yakovlev, E. V. Tigeeva, M. B. Borgoyakova, et al. (+6) E. V. Starostina, A. V. Zaikovskaya, A. P. Rudometov, N. B. Rudometova, L. I. Karpenko, A. A. Ilyichev
23	[GO]	2023―Nov―18	Artificial COVID-19 T-Cell Immunogen	M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, L. A. Kisakova, et al. (+4) D. N. Kisakov, S. V. Sharabrin, A. A. Ilyichev, S. I. Bazhan
24	[GO]	2023―Nov―03	Ratios between the levels of interleukin 18, free interleukin 18 and interleukin 18 binding protein depending on severity and outcome of COVID-19	А. А. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev
25	[GO]	2023―Nov―03	Safety assessment: a comparative analysis of bacterial endotoxin quantitative content and pyrogenicity determination of the Kazakhstan vaccine QazCovid-in® against COVID-19	K. K. Dzhekebekov, A. S. Nurpeisova, Zh. S. Abai, K. A. Shoraeva, Zh. S. Absatova, R. T. Abitaev, et al. (+10) E. Zh. Kalimolda, S. U. Moldagulova, N. N. Asanzhanova, A. D. Omurtai, E. A. Shayakhmetov, S. O. Sadikalieva, K. B. Barakbaev, M. M. Kasenov, K. D. Zakarya, E. O. Abduraimov
26	[GO]	2023―Okt―20	Ultrastructural Reorganization of Endotheliocytes of Pulmonary Blood Capillaries in COVID-19	N. P. Bgatova, S. V. Savchenko, A. N. Lamanov, M. Zh. Ergazina, M. T. Adilova, A. Yu. Letyagin
27	[GO]	2023―Aug―30	Distribution features of the OAS1 gene allelic variant associated with a severe form of the coronavirus infection in the Russian and global populations	M. V. Olkova, S. M. Koshel, V. S. Petrushenko, A. A. Alimov
28	[GO]	2023―Jul―19	The Search for Single-Domain Antibodies Interacting with the Receptor-Binding Domain of SARS-CoV-2 Surface Protein	V. S. Aripov, N. V. Volkova, A. V. Taranin, L. V. Mechetina, N. A. Chikaev, A. M. Nayakshin, et al. (+7) V. S. Nesmeyanova, A. A. Isaeva, Yu. A. Merkul’eva, D. V. Shanshin, S. V. Belenkaya, A. A. Ilyichev, D. N. Shcherbakov
29	[GO]	2023―Jun―28	Artificial COVID-19 T-cell immunogen	M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, L. A. Kisakova, et al. (+4) D. N. Kisakov, S. V. Sharabrin, A. A. Il'ichev, S. I. Bazhan
30	[GO]	2023―Jun―19	KDM5 Family Demethylase Inhibitor KDOAM-25 Reduces Entry of SARS-CoV-2 Pseudotyped Viral Particles into Cells	E. N. Knyazev, R. S. Kalinin, V. A. Abrikosova, Yu.A. Mokrushina, S. A. Tonevitskaya
31	[GO]	2023―Jun―01	Ultrastructural reorganization endotheliocytes of pulmonary blood capillaries in COVID-19	N. P. Bgatova, S. V. Savchenko, A. N. Lamanov, M. Zh. Ergazina, M. T. Adilova, A. Yu. Letyagin
32	[GO]	2023―Mrz―11	SARS-CoV-2 Mutations Lead to a Decrease in the Number of Tissue-Specific MicroRNA-Binding Regions in the Lung	A. P. Zhiyanov, M. Yu. Shkurnikov
33	[GO]	2023―Mrz―09	Pro-and Antioxidant Status in Newborn with COVID-19	L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, N. V. Semenova, E. V. Moskaleva, S. I. Kolesnikov, et al. (+2) A. S. Vanyarkina, L. I. Kolesnikova
34	[GO]	2023―Feb―22	Search for single-domain antibodies interacting with the receptor-binding domain of SARS-CoV-2 surface protein	V. S. Aripov, N. V. Volkova, A. V. Taranin, L. V. Mechetina, N. A. Chikaev, A. M. Nayakshin, et al. (+7) V. S. Nesmeyanova, A. A. Isaeva, Yu. A. Merkul'eva, D. V. Shanshin, S. V. Belenkaya, A. A. Ilyichev, D. N. Shcherbakov
35	[GO]	2023―Jan―04	Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19	M. B. Borgoyakova, L. I. Karpenko, I. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, et al. (+12) D. V. Shanshin, A. A. Isaeva, V. S. Nesmeyanova, N. V. Volkova, S. V. Belenkaya, E. A. Volosnikova, A. M. Zadorozhny, L. A. Orlova, A. V. Zaykovskaya, O. V. Pyankov, S. I. Bazhan, A. A. Ilyichev
36	[GO]	2022―Nov―04	Quantitative Assay of SARS-CoV-2 RNA and Level of Proinflammatory Protein Gene Transcripts in Peripheral Blood Leukocytes after a Novel Coronavirus Infection	L. V. Topchieva, O. V. Balan, A. V. Men’shenin, I. E. Malysheva, E. L. Tikhonovich
37	[GO]	2022―Nov―02	Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19	S. Yu. Kombarova, A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, A. M. Zatevalov, E. R. Mekhtiev, et al. (+13) T. E. Mizaeva, A. A. Basov, O. Yu. Borisova, E. I. Likhanskaya, E. A. Voropaeva, Yu. N. Urban, S. D. Mitrokhin, A. S. Shkoda, V. A. Gushchin, A. E. Sinyavin, M. A. Nikiforova, Yu. S. Lebedin, A. V. Karaulov
38	[GO]	2022―Okt―25	Pro- and antioxidant status in newborn with COVID-19	L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, N. V. Semenova, E. V. Moskaleva, S. I. Kolesnikov, et al. (+2) A. S. Vanyarkina, L. I. Kolesnikova
39	[GO]	2022―Okt―10	Changes in Spermatogenesis, Lipoperoxidation Processes, and Antioxidant Protection in Men with Pathozoospermia after COVID-19. The Effectiveness of Correction with a Promising Antioxidant Complex	N. A. Kurashova, B. G. Dashiev, S. I. Kolesnikov, P. S. Dmitrenok, E. P. Kozlovskaya, S. P. Kasyanov, et al. (+3) N. V. Epur, V. G. Usov, L. I. Kolesnikova
40	[GO]	2022―Sep―05	Mild or Moderate COVID-19 during Pregnancy Does Not Affect the Content of CD34+ Hematopoietic Stem Cells in Umbilical Cord Blood of Newborns	Yu. A. Romanov, Yu. A. Kosolapova, V. V. Zubkov, D. N. Degtyarev, A. Yu. Romanov, T. N. Dugina, G. T. Sukhikh
41	[GO]	2022―Sep―05	Changes in Some Vascular Biomarkers in Patients with Severe COVID-19 with Various Degrees of Pulmonary Hypertension	D. S. Shilin, K. G. Shapovalov
42	[GO]	2022―Sep―05	Cell and Organism Technologies for Assessment of the SARS-CoV-2 Infectivity in Fluid Environment	A. A. Shelemba, E. A. Kazachkova, Yu. V. Kononova, E. I. Kazachinskaya, M. Yu. Rukavishnikov, I. N. Kuvshinova, et al. (+3) M. I. Voevoda, A. M. Shestopalov, A. A. Chepurnov
43	[GO]	2022―Aug―29	The immunogenicity of the DNA/protein combinated vaccine against COVID-19	M. B. Borgoyakova, L. I. Karpenko, Yu. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, et al. (+12) D. V. Shan'shin, A. A. Isaeva, V. S. Nesmeyanova, N. V. Volkova, S. V. Belen'kaya, E. A. Volosnikova, A. M. Zadorozhny, L. A. Orlova, A. V. Zaikovskaya, O. V. P'yankov, S. I. Bazhan, A. A. Il'ichev
44	[GO]	2022―Jul―01	Features of the humoral response to infection, vaccination, and revaccination during Covid-19	S. Yu. Kombarova, A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, A. M. Zatevalov, E. R. Mekhtiev, et al. (+13) T. E. Mizaeva, A. A. Basov, O. Yu. Borisova, E. I. Likhanskaya, E. A. Voropaeva, Yu. N. Urban, S. D. Mitrokhin, A. S. Shkoda, V. A. Gushchin, A. E. Sinyavin, M. A. Nikiforova, Yu. S. Lebedin, A. V. Karaulov
45	[GO]	2022―Jul―01	Quantitative assessment of SARS-CoV-2 RNA and level of pro-inflammatory protein gene transcripts in PBMC after a novel coronavirus infection	L. V. Topchieva, O. V. Balan, A. V. Men'shenin, I. E. Malysheva, E. L. Tikhonovich
46	[GO]	2022―Jun―23	Development of a Test System to Detect the Omicron Variant of SARS-CoV-2 and the Frequency of Its Detection in Patients	M. L. Filipenko, I. P. Oskorbin, D. V. Shamovskaya, E. A. Kharpov, A. A. Stepanov, V. V. Romanov, et al. (+8) V. V. Kuznetsov, U. A. Boyarskikh, A. A. Kechin, E. V. Pechkovsky, A. B. Krivoruchko, A. M. Ivanov, N. E. Kushlinskii, V. V. Vlasov
47	[GO]	2022―Jun―06	Changes in spermatogenesis, lipoperoxidation processes and antioxidant protection in men with pathozoospermia after COVID-19 infection. The effectiveness of correction with a promising antioxidant complex	N. A. Kurashova, B. G. Dashiev, S. I. Kolesnikov, P. S. Dmitrenok, E. P. Kozlovskaya, S. P. Kas'yanov, et al. (+3) N. V. Epur, V. G. Usov, L. I. Kolesnikova
48	[GO]	2022―Mai―28	Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects	N. N. Sushentseva, O. S. Popov, I. A. Polkovnikova, S. V. Al’pako, S. G. Shcherbak
49	[GO]	2022―Mai―27	Morphofunctional Characteristics of Erythrocytes and Blood Erythropoietin Level in Patients as Predictors of Severe Course of COVID-19	V. V. Revin, L. A. Balykova, O. A. Radaeva, V. V. Shchapov, E. S. Revina, S. I. Pinyaev, et al. (+2) Yu. A. Kostina, E. D. Kozlov
50	[GO]	2022―Mai―27	Superoxide Dismutase Activity in Male and Female Patients of Different Age with Moderate COVID-19	N. V. Semenova, L. V. Rychkova, M. A. Darenskaya, S. I. Kolesnikov, O. A. Nikitina, A. G. Petrova, et al. (+2) E. V. Vyrupaeva, L. I. Kolesnikova
51	[GO]	2022―Mai―27	Peculiarities of Humoral Immunity Formation in Medical Institution Employees Recovered from or Vaccinated against COVID-19 in Irkutsk	V. I. Dubrovina, D. D. Bryukhova, N. O. Kiseleva, M. V. Chesnokova, K. M. Korytov, A. B. Pyatidesyatnikova, et al. (+2) V. A. Vishnyakov, S. V. Balakhonov
52	[GO]	2022―Mai―02	Reduced Counts of Various Subsets of Peripheral Blood T Lymphocytes in Patients with Severe Course of COVID-19	C. Zhao, X. Hu, Q. Xue, L. Chen
53	[GO]	2022―Apr―28	Changes in some vascular biomarkers in patients with severe COVID-19 with various degrees of pulmonary hypertension	D. S. Shilin, K. G. Shapovalov
54	[GO]	2022―Feb―24	Development of a test system to detect the omicron variant of SARS-CoV-2 and the frequency of its detection in patients	M. L. Philipenko, I. P. Oskorbin, D. V. Shamovskaya, E. A. Kharpov, A. A. Stepanov, V. V. Romanov, et al. (+8) V. V. Kuznetsov, U. A. Boyarskikh, A. A. Kechin, E. V. Pechkovsky, A. B. Krivoruchko, A. M. Ivanov, N. E. Kushlinsky, V. V. Vlasov
55	[GO]	2022―Jan―25	Morphofunctional characteristics of erythrocytes and blood erythropoietin level in patients as predictors of severe COVID-19	V. V. Revin, L. A. Balikova, O. A. Radaeva, V. V. Shchapov, E. S. Revina, S. I. Pinyaev, et al. (+2) Yu. A. Kostina, E. D. Kozlov
56	[GO]	2022―Jan―25	Superoxide dismutase activity in patients of different sex and age with middle severity COVID-19	N. V. Semenova, L. V. Richkova, M. A. Darenskaya, S. I. Kolesnikov, O. A. Nikitina, A. G. Petrova, et al. (+2) E. V. Virupaeva, L. I. Kolesnikova
57	[GO]	2022―Jan―25	Peculiarities of humoral immunity formation among medical institution employees that have been recover or vaccinated against COVID-19 in Irkutsk	V .I. Dubrovina, D. D. Bryukhova, N. O. Kiseleva, M. V. Chesnokova, K. M. Korytov, A. B. Pyatidesyatnikova, et al. (+2) V. A. Vishnyakov, S. V. Balakhonov
58	[GO]	2022―Jan―08	The Role of Na+/K+-ATPase in the Development of Hyponatrenemia under Conditions of Hypoxic Stress in Patients with SARS-CoV-2 Infection	S. H. Jafarova, S. A. Adnaev, R. T. Guliyeva, N. H. Jafar
59	[GO]	2021―Nov―18	Morphometric Parameters of Placental Villi in Parturient Women with COVID-19	A. I. Shchegolev, G. V. Kulikova, U. N. Tumanova, R. G. Shmakov, G. T. Sukhikh
60	[GO]	2021―Nov―18	Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2	P. G. Madonov, V. A. Svyatchenko, S. S. Legostaev, N. A. Kikhtenko, A. A. Kotlyarova, L. A. Oleinik, G. I. Baikalov
61	[GO]	2021―Nov―17	Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology	A. A. Chepurnov, E. I. Kazachinskaya, E. A. Kazachkova, K. A. Sharshov, Yu. V. Kononova, A. A. Shelemba, et al. (+4) A. Yu. Alekseev, M. A. Gulyeva, M. I. Voevoda, A. M. Shestopalov
62	[GO]	2021―Sep―30	The role of Na+/K+-ATPase in the development of hyponatrenemia under hypoxic stress in patients with SARS-CoV-2	S. H. Jafarova, S. A. Adnaev, R. T. Guliyeva, N. H. Jafar
63	[GO]	2021―Sep―20	The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19	B. I. Kuznik, Yu. N. Smolyakov, Yu. K. Shapovalov, K. G. Shapovalov, S. A. Lukyanov, D. S. Parts
64	[GO]	2021―Aug―02	Increased numbers of syncytial knots and high VEGF expression levels in placental villi among parturient women with COVID-19 depend on the disease severity	A. I. Shchegolev, G. V. Kulikova, U. N. Tumanova, R. G. Shmakov, G. T. Sukhikh
65	[GO]	2021―Aug―02	Development of a purified viral preparation for research of COVID-19 (SARS-CoV-2) biology	A. A. Chepurnov, E. I. Kazachinskaya, E. A. Kazachkov, K. A. Sharshov, Yu. V. Kononova, A. A. Shelemba, et al. (+4) A. Yu. Alekseev, M. A. Gulyaeva, M. I. Voevoda, A. M. Shestopalov
66	[GO]	2021―Aug―02	Evaluation of the anti-viral activity of the human recombinant interferon lambda-1 against SARS-CoV-2	P. G. Madonov, V. A. Svyatchenko, S. S. Legostaev, N. A. Kikhtenko, A. A. Kotlyarova, L. A. Oleynik, G. I. Baykalov
67	[GO]	2021―Jul―22	The Number of Syncytial Knots and VEGF Expression in Placental Villi in Parturient Woman with COVID-19 Depends on the Disease Severity	A. I. Shchegolev, G. V. Kulikova, V. M. Lyapin, R. G. Shmakov, G. T. Sukhikh
68	[GO]	2021―Jun―26	Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection	A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, S. Yu. Kombarova, Yu. S. Lebedin, A. M. Vorob’ev, et al. (+4) E. R. Mekhtiev, E. R. Zul’karneev, A. I. Laishevtsev, A. V. Karaulov
69	[GO]	2021―Apr―27	The state of microcirculatory hemodynamics in patients with moderate and severe COVID-19	B. I. Kuznik, Yu. N. Smolyakov, Yu. K. Shapovalov, K. G. Shapovalov, S. A. Lukyanov, D. S. Parts
70	[GO]	2021―Mrz―22	The number of syncytial knots and VEGF expression in placental villi among parturient women with COVID-19 depends on the disease severity	A. I. Shchegolev, G. V. Kulikova, V. M. Lyapin, R. G. Shmakov, G. T. Sukhikh
71	[GO]	2021―Feb―16	Dynamics of antibodies to various antigens of the SARS-CoV-2 coronavirus in patients with confirmed COVID-19 infection	A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, S. Iu. Kombarova, Iu. S. Lebedin, A. M. Vorobev, et al. (+4) E. R. Mekhtiev, E. R. Zulkarneev, A. I. Laishevtsev, A. V. Karaulov